Presence of anti-platelet IgM and IgG antibodies in dogs naturally infected by Leishmania infantum

Thirty-three dogs, naturally infected by Leishmania infantum, were enrolled in the study and were classified as oligo-symptomatic (n. 15) and symptomatic or markedly symptomatic (n. 18). A control group was 10 healthy dogs. A haematological profile was obtained and the dogs serum was employed to assess the presence of platelet binding IgM and IgG antibodies (PBIgM, PBIgG) using flow cytometry. FITC labelled goat anti-dog IgM or IgG were used to detect PBIgM and PBIgG. Samples with a mean fluorescence intensity (MFI) that was 100 channels higher on a log scale for more than 30% of the platelets than seen in negative control platelets from a healthy dog were considered positive for the presence of anti-platelet antibodies (PBIg). Twenty-one (63.3%) dogs revealed the presence of PBIg. Six of them were oligo-symptomatic while 15 showed moderate or severe clinical signs of illness. All the dogs with PBIg showed the presence of PBIgM, with nine animals showing both PBIgM and PBIgG. Nine of 18 symptomatic or markedly symptomatic dogs showed thrombocytopenia, while normal platelet counts were observed in all oligo-symptomatic animals. Eight of 9 thrombocytopenic animals showed the presence of PBIgM, while six of them showed PBIgG. One thrombocytopenic dog was negative for PBIg. This study is the first report documenting the presence of PBIg in natural canine leishmaniasis implying a pathogenic association between thrombocytopenia and the presence of antibody against platelet membrane.     

检测犬源狂犬病毒中和抗体ELISA方法的建立

为了有效监测犬免疫狂犬病疫苗后的保护效力,以狂犬病毒(Rabies virus,RV)糖蛋白的主要优势抗原表位区G3蛋白(RV G3)作为包被抗原,建立了一种检测狂犬病毒中和抗体效价的间接ELISA方法.通过优化反应条件,确定抗原最佳包被量为8 mg/L,血清的最佳稀释度为1∶100,酶标二抗的稀释度为1∶3 000.特异性试验表明,该抗原不与犬瘟热病毒、犬腺病毒、犬细小病毒阳性血清发生交叉反应;批内和批间重复性试验的平均变异系数都小于10%;敏感性达1∶1 280.此方法检测134份血清样品的结果与美国SYNBIOTICS试剂盒相比,总符合率达95.6%.     

Effect of a difficult calving on the vigour of the calf, the onset of maternal behaviour, and some behavioural indicators of pain in the dam

The neonate's development and survival is dependent upon being vigorous at birth and receiving appropriate maternal care. However, difficulty at delivery can result in less vigorous offspring and maternal care can be altered, probably as a consequence of exhaustion, pain and human intervention. The first 3 h after expulsion of the calf were observed continuously from videos following twelve natural calvings and sixteen calvings assisted by farm staff (including four malpresentations) from Holstein cows. Calvings were balanced within groups for parity of the dam, genetic group, sex and birth weight of the calf, calving pen and calving season. Assisted calves were less vigorous with higher latencies to attempt to stand, achieve standing, walk and reach the udder than unassisted calves (P < 0.05). Furthermore, assisted calves also tended to be less likely to stand and walk within the first 3 h after birth (P < 0.1), spent more time lying on their flank (P = 0.019) and had more frequent bouts of this behaviour (P = 0.033). Assisted dams did not take longer to lick the calf and performed as much licking as unassisted dams (P > 0.05), indicating no delayed onset or impaired expression of maternal behaviour in dams given assistance at delivery. Study of potential pain-related behaviours revealed that assisted dams spent less time self-grooming (P = 0.033) than dams delivering naturally, which could suggest greater pain. However, there were no significant differences in any of the other pain-related behaviours. Our results suggest that, although maternal behaviour was unaffected by a difficult delivery, dairy calves born following difficult calvings have lower vigour in the first 3 h after birth than unassisted calves. This might have longer-term effects on the health and survival of the calves.     

牛朊蛋白和酵母朊毒体结构域融合蛋白的原核表达及其单克隆抗体的制备

利用DNA重组技术将酵母Ure2p朊蛋白结构域(UPD)基因插入牛朊蛋白(BPrP)表达质粒pET-PrP中,构建原核表达载体pET-PrP-UPD.阳性质粒转化宿主菌BL21 (DE3),在IPTG诱导下获得高效表达.Westernblot检测表明表达的重组蛋白与单克隆抗体6H4呈现特异性反应,且纯化的PrP-UPD融合蛋白在体外具有聚集成淀粉样纤维、抵抗蛋白酶K消化等朊毒体的结构特点.利用纯化的PrP-UPD免疫BALB/c小鼠,取其脾细胞与SP2/0细胞融合,经克隆和筛选,获得3株稳定分泌抗重组PrP单抗的杂交瘤细胞,分别命名为1G3、3A4、4D1,其中1G3分泌的单抗能识别细胞型牛朊蛋白,其Ig亚类为IgG2b,腹水ELISA效价为1×105,Western blot表明该单抗具有较强的特异性.     

抗ICAM-1单克隆抗体的生物学功能研究

本研究通过体外细胞试验和体内动物试验,对已制备的抗细胞间粘附分子1(ICAM-1)单克隆抗体(MAb)4F1和2C5的生物学活性进行检测.间接免疫荧光试验表明:这两株ICAM-1 MAb可以与人血管内皮细胞ECV304细胞中的ICAM-1结合.以乳酸脱氢酶释放法检测ICAM-1 MAb抑制单核细胞与血管内皮细胞的黏附作用.4F1和2C5 MAb分别可以使细胞黏附降低34.4％和26.9％.二甲苯致小鼠耳廓肿胀试验和毛细血管通透性试验表明:ICAM-1 MAb能够抑制小鼠耳廓肿胀度,使伊文思蓝渗出量降低.本研究证明所制备的MAb均具有阻断ICAM-1及抑制炎症反应的功能,其中4F1生物学活性高于2C5.     

非洲猪瘟病原学及单克隆抗体制备技术研究进展

非洲猪瘟是由非洲猪瘟病毒引起猪的高度接触性、传染性、出血性以及高死亡率的传染病。20世纪中期以来,已在非洲、欧洲和美洲等数十个国家流行,并在近几年内蔓延至欧亚两洲接壤处的格鲁吉亚、亚美尼亚、阿塞拜疆以及俄罗斯境内,其一旦侵入我国,将会给我国养猪业带来极大的危害。非洲猪瘟病原学研究以及制备相应的单克隆抗体对非洲猪瘟病毒快速诊断技术研究和疫苗研制有着重大的现实意义。主要从病原学和单克隆抗体制备方面对非洲猪瘟的研究进展进行了综述。     

牛病毒性腹泻病毒Core蛋白的原核表达及多克隆抗体制备

为制备牛病毒性腹泻病毒(BVDV)的Core蛋白及其多克隆抗体,根据Core蛋白的编码基因序列,设计合成一对特异性引物,利用RT-PCR扩增BVDV Core基因并定向插入Pet30a载体中,构建重组质粒Pet30a-Core,经酶切鉴定后转化大肠埃希菌TOP 10感受态细胞,筛选获得阳性重组菌,以IPTG进行诱导后成功表达出分子质量为20 ku的重组Core蛋白。将诱导表达的蛋白产物经融合蛋白的Ni柱亲和法进行纯化,利用纯化的重组蛋白免疫新西兰白兔制备多克隆抗体,并利用间接ELISA法测出多克隆抗体效价达到1∶512 000。蛋白质印迹法(Western blot)和间接免疫荧光试验(IFA)证实,多克隆抗体可与细胞中的BVDV抗原发生反应,具有良好的免疫原性和特异性。本实验成功制备了BVDV重组Core蛋白的兔源多克隆抗体,为BVDV的检测及其Core蛋白功能研究奠定了基础。     

隐孢子虫病抗体治疗的研究进展

从超免疫初乳、超免疫血清、超免疫卵黄和单克隆抗体几个方面概述了国内外隐孢子虫病抗体治疗的研究现状,并介绍了预防隐孢子虫病疫苗的研究成果,为进一步防治该病提供了参考。